Curaleaf Presses Aurora Shareholders to Accept Takeover Bid — Curaleaf Holdings, Inc.

Event summary

Curaleaf offered a 45% premium to Aurora shareholders, proposing 0.3463 Curaleaf shares and $0.75 cash per Aurora share.
The combined entity would operate in 17 countries with $1.5B in 12-month revenue and $350M in adjusted EBITDA.
Aurora's revenue and adjusted EBITDA declined 14% and 78% respectively over the four quarters ended June 30, 2026.
Curaleaf's offer deadline is December 1, 2026.
Boris Jordan will host a live Q&A for Aurora shareholders on September 17, 2026.

The big picture

Curaleaf's aggressive push to acquire Aurora highlights the ongoing consolidation in the cannabis sector, as larger players seek to capture scale and profitability amid regulatory uncertainty. The deal, if successful, would create the world's largest cannabis company, with operations spanning 17 countries and significant revenue and EBITDA. However, Aurora's declining financial performance and Curaleaf's need to secure shareholder approval present significant hurdles.

What we're watching

Shareholder Response: Whether Aurora shareholders will accept Curaleaf's offer given the 45% premium and the company's financial struggles.
Regulatory Approval: The pace at which regulatory approvals for the deal will be secured, given the cross-border nature of the transaction.
Integration Challenges: How Curaleaf will manage the integration of Aurora's operations, particularly given the expected $40M in annual cost synergies.